Low incidence of neurologic events during long-term support with the HeartMate® XVE left ventricular assist device

Texas Heart Institute Journal

Volumn 35, Issue 3, 2008, Pages 245-249

  Slaughter, Mark S ^a,b   Sobieski, Michael A ^a   Gallagher, Colleen ^a   Dia, Muhyaldeen ^a   Silver, Marc A ^a  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Biocompatible materials; Brain injuries; Cerebrovascular disorders; Equipment design; Heart failure surgery therapy; Heart assist devices; Neurologic examination; Thromboembolism prevention control; Trail making test; Word association tests

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HUMAN; INCIDENCE; LONG TERM CARE; MALE; METABOLIC ENCEPHALOPATHY;

ADULT; AGED; ASPIRIN; BRAIN DISEASES, METABOLIC; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; COGNITION DISORDERS; EQUIPMENT DESIGN; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LONG-TERM CARE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STROKE; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 56049127755     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Copeland JG 3rd, Smith RG, Arabia FA, Nolan PE, Mehta VK, McCarthy MS, Chisholm KA. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg 2001;71(3 Suppl):S92-7.
2. McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, Young JB. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115(4):904-12.
3. Rose EA, Levin HR, Oz MC, Frazier OH, MacManus Q, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation 1994;90(5 Pt 2):II87-91.
4. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg AD, Oz MC. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996;62(5):1321-8.
5. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67(3):723-30.
6. Lazar RM, Shapiro PA, Jaski BE, Parides MK, Bourge RC, Watson JT, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 2004;109(20):2423-7.
7. Pae WE, Connell JM, Boehmer JP, Korfer R, El-Banayosy A, Hetzer R, et al. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant 2007;26(1):1-8.
8. Radovancevic B, Frazier OH, Duncan JM. Implantation technique for the HeartMate left ventricular assist device. J Card Surg 1992;7(3):203-7.
9. Spilker J, Kongable G, Barch C, Braimah J, Brattina P, Daley S, et al. Using the NIH Stroke Scale to assess stroke patients. The NINDs rt-PA Stroke Study Group. J Neurosci Nurs 1997;29(6):384-92.
10. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19(5):604-7.
11. Suzuki M, Omori M, Hatakeyama M, Yamada S, Matsushita K, Iijima S. Predicting recovery of upper-body dressing ability after stroke. Arch Phys Med Rehabil 2006;87(11):1496-502.
12. Zec RF, Burkett NR, Markwell SJ, Larsen DL. Normative data stratified for age, education, and gender on the Boston Naming Test. Clin Neuropsychol 2007;21(4):617-37.
13. Yochim B, Baldo J, Nelson A, Delis DC. D-KEFS Trail Making Test performance in patients with lateral prefrontal cortex lesions. J Int Neuropsychol Soc 2007;13(4):704-9.
14. Burnett CM, Duncan JM, Frazier OH, Sweeney MS, Vega JD, Radovancevic B. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg 1993;55(1):65-71.
15. Dasse KA, Frazier OH, Lesniak JM, Myers T, Burnett CM, Poirier VL. Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J 1992;38(3):M622-6.
16. Dowling RD, Park SJ, Pagani FD, Tector AJ, Naka Y, Icenogle TB, et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 2004;25(6):958-63.
17. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005;11(3):133-8.
18. Scott-Burden T, Tock CL, Bosely JP, Clubb FJ Jr, Parnis SM, Schwarz JJ, et al. Nonthrombogenic, adhesive cellular lining for left ventricular assist devices. Circulation 1998;98(19 Suppl):II339-45.
19. Graham TR, Dasse K, Coumbe A, Salih V, Marrinan MT, Frazier OH, Lewis CT. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg 1990;4(4):182-90.
20. Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004;23(8):964-9.